At a glance
- Originator Merck & Co
- Class Acetamides; Antithrombotics
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 24 Apr 1998 New profile
- 24 Apr 1998 Preclinical development for Thrombosis in USA (Unknown route)